SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Aspen Neuroscience Plans to Go Public

The San Diego biotech is developing a therapy to replace brain cells lost to Parkinson’s. The headline says it is going public.

Related stories